Atlas Trials

Personalized Targeted Inhibitors Treatment in Renal Cell Cancer

Clinical trial NCT02560012 · TERMINATED

Trial details

NCT number
NCT02560012
Sponsor
The University of Texas Health Science Center, Houston
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Renal Cell
Start date
2016-01-04
Primary completion
2017-07-27
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.